Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
GRGerd R BurmesterRBRicardo BlancoCCChristina Charles‐SchoemanJWJ. WollenhauptCACristiano A. F. Zerbini
Charité - Universitätsmedizin Berlin · Marqués de Valdecilla University Hospital · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
717
total citations
- FWCI
- 53.93
- Percentile
- 100%
- References
- 23
Citations per year
Authors
14- GRGerd R BurmesterCorresponding
Charité - Universitätsmedizin Berlin
- RBRicardo Blanco
Marqués de Valdecilla University Hospital
- CCChristina Charles‐Schoeman
University of California, Los Angeles
- JWJ. Wollenhaupt
Schön Klinik Hamburg Eilbek, Universität Hamburg
- CACristiano A. F. Zerbini
Hospital Heliópolis, Centro Paulista de Investigação Clinica
Topics & keywords
Topics
Keywords
- Tofacitinib
- Medicine
- Rheumatoid arthritis
- Janus kinase inhibitor
- Internal medicine
- Placebo
- Rheumatology
- Methotrexate
No related works found for this paper.